AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $1.27 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2019-03-29
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2017 was $1.27.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2015 was $1.23.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2017-12-31 | $1.27 10-K · filed 2019-03-29 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-27 |
| 2015-12-31 | $1.23 10-K · filed 2016-03-30 |
| 2014-12-31 | $0.00 10-K · filed 2015-04-01 |
| 2013-12-31 | $1.46 10-K · filed 2014-03-31 |
| 2012-12-31 | $1.51 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |